US High Growth Tech: 3 Stocks to Watch [Yahoo! Finance]
Marker Therapeutics, Inc. (MRKR)
Last marker therapeutics, inc. earnings: 11/12 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
confidence, attention turns to high-growth opportunities within the tech sector. In this environment, identifying promising stocks involves looking for companies that demonstrate robust innovation and adaptability to capitalize on emerging trends such as AI and cloud computing. Name Revenue Growth Earnings Growth Growth Rating Marker Therapeutics ?????? Palantir Technologies ?????? Workday ?????? Circle Internet Group ?????? Atlassian ?????? RenovoRx ?????? Viridian Therapeutics ?????? Zscaler ?????? Procore Technologies ?????? Duos Technologies Group ?????? Click here to see the full list of 76 stocks from our US High Growth Tech and AI Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Growth Rating: ?????? Overview: Workday, Inc. is a company that offers enterprise cloud applications both in the United States and internationally, with a market capitalization of $57.50 billion. Operations:
Show less
Read more
Impact Snapshot
Event Time:
MRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRKR alerts
High impacting Marker Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
MRKR
News
- Marker Therapeutics (NASDAQ:MRKR) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.MarketBeat
- Marker Therapeutics (NASDAQ:MRKR) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.MarketBeat
- Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=MRKR&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StrMarketBeat
MRKR
Sec Filings
- 11/19/25 - Form 4
- 11/19/25 - Form 4
- 11/19/25 - Form 4
- MRKR's page on the SEC website